首页|期刊导航|Oncology Research|miR-512-3p/RPS6KA2 Axis Regulates Cisplatin Resistance in Ovarian Cancer via Autophagy and Ferroptosis

miR-512-3p/RPS6KA2 Axis Regulates Cisplatin Resistance in Ovarian Cancer via Autophagy and Ferroptosis

Jianfa Wu Huang Chen Sihong Wang Lei Peng Xiaoying Hu Zhou Liu

Oncology Research2026，Vol.34Issue(1)：P.568-597,30.

Oncology Research2026，Vol.34Issue(1)：P.568-597,30.DOI:10.32604/or.2025.070542

miR-512-3p/RPS6KA2 Axis Regulates Cisplatin Resistance in Ovarian Cancer via Autophagy and Ferroptosis

Jianfa Wu ¹Huang Chen ²Sihong Wang ³Lei Peng ³Xiaoying Hu ³Zhou Liu³

作者信息

1. Department of Gynecology,Shanghai University of Medicine&Health Sciences Affiliated Zhoupu Hospital,Shanghai,201318,China Department of Gynecology,Shanghai University of Medicine&Health Sciences,Shanghai,201318,China Department of Integrated Traditional Chinese and Western Medicine Clinical Practice,Shanghai University of Traditional Chinese Medicine,Shanghai,200032,China
2. Department of Integrated Traditional Chinese and Western Medicine Clinical Practice,Shanghai University of Traditional Chinese Medicine,Shanghai,200032,China
3. Department of Gynecology,Shanghai University of Medicine&Health Sciences Affiliated Zhoupu Hospital,Shanghai,201318,China Department of Gynecology,Shanghai University of Medicine&Health Sciences,Shanghai,201318,China
折叠

摘要

关键词

RPS6KA2/autophagy/ovarian cancer/ferroptosis/chemoresistance

分类

医药卫生

引用本文复制引用

Jianfa Wu,Huang Chen,Sihong Wang,Lei Peng,Xiaoying Hu,Zhou Liu..miR-512-3p/RPS6KA2 Axis Regulates Cisplatin Resistance in Ovarian Cancer via Autophagy and Ferroptosis[J].Oncology Research,2026,34(1):P.568-597,30.

基金项目

supported by the Academic Leader Training Programof Pudong New Area Health System in Shanghai(Grant No.PWRd2021-13) （Grant No.PWRd2021-13）

Shanghai Municipal Health Commission(Grant No.202340094). （Grant No.202340094）

Oncology Research

ISSN：0965-0407

访问量0

下载量0

段落导航